vs
NEOGEN CORP（NEOG）与GIBRALTAR INDUSTRIES, INC.（ROCK）财务数据对比。点击上方公司名可切换其他公司
GIBRALTAR INDUSTRIES, INC.的季度营收约是NEOGEN CORP的1.0倍（$225.0M vs $224.7M），GIBRALTAR INDUSTRIES, INC.同比增速更快（24.9% vs -2.8%），GIBRALTAR INDUSTRIES, INC.自由现金流更多（$26.2M vs $7.8M），过去两年NEOGEN CORP的营收复合增速更高（-0.9% vs -12.3%）
Neogen Corporation是一家1982年成立、总部位于美国密歇根州兰辛的跨国食品安全企业，专注提供各类检测试剂盒及相关产品，用于筛查食品中的有害成分。目前业务覆盖美国、加拿大、英国、欧洲部分地区、墨西哥、巴西、印度、中国等多个国家，旗下拥有超100款药物检测试剂盒产品，可检测约300种相关违禁物质。
直布罗陀工业公司是专业建筑、基础设施及可再生能源产品制造商与分销商，主营通风系统、屋面配件、太阳能安装支架、园林景观产品等，主要服务北美地区住宅、商业建筑及清洁能源市场，专注提供创新可持续的客户解决方案。
NEOG vs ROCK — 直观对比
营收规模更大
ROCK
是对方的1.0倍
$224.7M
营收增速更快
ROCK
高出27.8%
-2.8%
自由现金流更多
ROCK
多$18.4M
$7.8M
两年增速更快
NEOG
近两年复合增速
-12.3%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $224.7M | $225.0M |
| 净利润 | $-15.9M | — |
| 毛利率 | 47.5% | 25.3% |
| 营业利润率 | -2.4% | 7.9% |
| 净利率 | -7.1% | — |
| 营收同比 | -2.8% | 24.9% |
| 净利润同比 | 96.5% | — |
| 每股收益（稀释后） | $-0.07 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NEOGROCK
| Q4 25 | $224.7M | $225.0M | ||
| Q3 25 | $209.2M | $310.9M | ||
| Q2 25 | $225.4M | $309.5M | ||
| Q1 25 | $221.0M | $290.0M | ||
| Q4 24 | $231.3M | $180.1M | ||
| Q3 24 | $217.0M | $277.1M | ||
| Q2 24 | $236.8M | $273.6M | ||
| Q1 24 | $228.8M | $292.5M |
净利润NEOGROCK
| Q4 25 | $-15.9M | — | ||
| Q3 25 | $36.3M | $-89.1M | ||
| Q2 25 | $-612.3M | $26.0M | ||
| Q1 25 | $-10.9M | $21.1M | ||
| Q4 24 | $-456.3M | — | ||
| Q3 24 | $-12.6M | $34.0M | ||
| Q2 24 | $-5.4M | $32.2M | ||
| Q1 24 | $-2.0M | $24.9M |
毛利率NEOGROCK
| Q4 25 | 47.5% | 25.3% | ||
| Q3 25 | 45.4% | 26.6% | ||
| Q2 25 | 41.2% | 28.4% | ||
| Q1 25 | 49.9% | 26.8% | ||
| Q4 24 | 49.0% | 29.0% | ||
| Q3 24 | 48.4% | 29.4% | ||
| Q2 24 | 47.9% | 30.5% | ||
| Q1 24 | 51.1% | 28.9% |
营业利润率NEOGROCK
| Q4 25 | -2.4% | 7.9% | ||
| Q3 25 | -7.7% | 12.8% | ||
| Q2 25 | -271.1% | 12.8% | ||
| Q1 25 | 2.4% | 8.8% | ||
| Q4 24 | -197.8% | 13.3% | ||
| Q3 24 | 1.0% | 15.6% | ||
| Q2 24 | 5.5% | 14.9% | ||
| Q1 24 | 5.3% | 10.8% |
净利率NEOGROCK
| Q4 25 | -7.1% | — | ||
| Q3 25 | 17.4% | -28.6% | ||
| Q2 25 | -271.6% | 8.4% | ||
| Q1 25 | -4.9% | 7.3% | ||
| Q4 24 | -197.3% | — | ||
| Q3 24 | -5.8% | 12.3% | ||
| Q2 24 | -2.3% | 11.8% | ||
| Q1 24 | -0.9% | 8.5% |
每股收益（稀释后）NEOGROCK
| Q4 25 | $-0.07 | — | ||
| Q3 25 | $0.17 | $-2.98 | ||
| Q2 25 | $-2.82 | $0.87 | ||
| Q1 25 | $-0.05 | — | ||
| Q4 24 | $-2.10 | — | ||
| Q3 24 | $-0.06 | $1.11 | ||
| Q2 24 | $-0.02 | $1.05 | ||
| Q1 24 | $-0.01 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $145.3M | $115.7M |
| 总债务越低越好 | — | $0 |
| 股东权益账面价值 | $2.1B | $950.4M |
| 总资产 | $3.4B | $1.4B |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资NEOGROCK
| Q4 25 | $145.3M | $115.7M | ||
| Q3 25 | $138.9M | $89.4M | ||
| Q2 25 | $129.0M | $43.3M | ||
| Q1 25 | $127.7M | $25.1M | ||
| Q4 24 | $140.2M | $269.5M | ||
| Q3 24 | $120.5M | $228.9M | ||
| Q2 24 | $170.9M | $179.1M | ||
| Q1 24 | $168.4M | $146.7M |
总债务NEOGROCK
| Q4 25 | — | $0 | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $0 | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | $0 |
股东权益NEOGROCK
| Q4 25 | $2.1B | $950.4M | ||
| Q3 25 | $2.1B | $951.8M | ||
| Q2 25 | $2.1B | $1.0B | ||
| Q1 25 | $2.7B | $1.0B | ||
| Q4 24 | $2.7B | $1.0B | ||
| Q3 24 | $3.1B | $1.0B | ||
| Q2 24 | $3.1B | $975.7M | ||
| Q1 24 | $3.1B | $940.2M |
总资产NEOGROCK
| Q4 25 | $3.4B | $1.4B | ||
| Q3 25 | $3.4B | $1.4B | ||
| Q2 25 | $3.4B | $1.5B | ||
| Q1 25 | $4.0B | $1.4B | ||
| Q4 24 | $4.1B | $1.4B | ||
| Q3 24 | $4.5B | $1.4B | ||
| Q2 24 | $4.5B | $1.4B | ||
| Q1 24 | $4.6B | $1.3B |
负债/权益比NEOGROCK
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.4M | $35.5M |
| 自由现金流经营现金流 - 资本支出 | $7.8M | $26.2M |
| 自由现金流率自由现金流/营收 | 3.5% | 11.7% |
| 资本支出强度资本支出/营收 | 5.2% | 4.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-18.5M | $120.6M |
8季度趋势，按日历期对齐
经营现金流NEOGROCK
| Q4 25 | $19.4M | $35.5M | ||
| Q3 25 | $10.9M | $73.0M | ||
| Q2 25 | $16.4M | $44.9M | ||
| Q1 25 | $19.5M | $13.7M | ||
| Q4 24 | $40.3M | $19.9M | ||
| Q3 24 | $-17.9M | $64.7M | ||
| Q2 24 | $26.7M | $36.5M | ||
| Q1 24 | $-30.2M | $53.2M |
自由现金流NEOGROCK
| Q4 25 | $7.8M | $26.2M | ||
| Q3 25 | $-13.1M | $64.8M | ||
| Q2 25 | $349.0K | $27.3M | ||
| Q1 25 | $-13.4M | $2.3M | ||
| Q4 24 | $23.1M | $14.1M | ||
| Q3 24 | $-56.3M | $60.5M | ||
| Q2 24 | $2.5M | $33.5M | ||
| Q1 24 | $-62.3M | $48.8M |
自由现金流率NEOGROCK
| Q4 25 | 3.5% | 11.7% | ||
| Q3 25 | -6.3% | 20.8% | ||
| Q2 25 | 0.2% | 8.8% | ||
| Q1 25 | -6.1% | 0.8% | ||
| Q4 24 | 10.0% | 7.8% | ||
| Q3 24 | -26.0% | 21.8% | ||
| Q2 24 | 1.1% | 12.2% | ||
| Q1 24 | -27.2% | 16.7% |
资本支出强度NEOGROCK
| Q4 25 | 5.2% | 4.1% | ||
| Q3 25 | 11.5% | 2.6% | ||
| Q2 25 | 7.1% | 5.7% | ||
| Q1 25 | 14.9% | 3.9% | ||
| Q4 24 | 7.4% | 3.3% | ||
| Q3 24 | 17.7% | 1.5% | ||
| Q2 24 | 10.2% | 1.1% | ||
| Q1 24 | 14.0% | 1.5% |
现金转化率NEOGROCK
| Q4 25 | — | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | — | 1.73× | ||
| Q1 25 | — | 0.65× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | — | 1.13× | ||
| Q1 24 | — | 2.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NEOG
| Other | $109.2M | 49% |
| Bacterial And General Sanitation | $44.9M | 20% |
| Services | $25.7M | 11% |
| Natural Toxins And Allergens | $20.4M | 9% |
| Animal Care | $8.9M | 4% |
| Genomics Services | $6.3M | 3% |
| Biosecurity Products | $4.6M | 2% |
| Life Sciences | $1.4M | 1% |
ROCK
| Transferred At Point In Time | $183.5M | 82% |
| Infrastructure | $22.5M | 10% |
| Other | $18.9M | 8% |
